AliveCor gets FDA clearance for feature to measure QT interval

AliveCor gets FDA clearance for feature to measure QT interval

Source: 
MedCity News
snippet: 

AliveCor's at-home EKG device won FDA clearance to calculate a heart's QT interval, a measurement of how long it takes the ventricles to contract and relax. This is vital given that some drugs can lead to QT prolongation, which can increase the risk of certain arrhythmias.